Eastern Arc researchers at the University of East Anglia based in the Quadram Institute and the School of Biosciences at the University of Kent are working to help generate a vaccine against coronavirus and providing […]
Lodo Therapeutics Corp., a biotechnology company applying its proprietary platform to reinvent natural product drug discovery, today announced it has achieved a preclinical milestone in its multi-target strategic collaboration with Genentech, a member of the […]
OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announced today that it has completed enrollment in its Oxabact ePHex phase III study. Oxabact is an investigational […]
Gilead Sciences, Inc. (Nasdaq: GILD) and Second Genome, a leader in microbiome science, today announced that the companies have entered into a four-year strategic collaboration to identify biomarkers associated with clinical response in up to […]
Big data makes big promises when it comes to providing insights into human behavior and health. The problem is how to harness the information it provides in an efficient manner. An international team of researchers […]
Cancer mutations can be caused by common gut bacteria carried by many people. This was demonstrated by researchers from the Hubrecht Institute (KNAW) and Princess Máxima Center in Utrecht, the Netherlands. By exposing cultured human […]
“We are living through an explosion in the availability of microbiome data,” according to JP Dundore-Arias, assistant professor of plant pathology at California State University, Monterey Bay. “In agricultural systems, the proliferation of research on […]
In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, Allergan and Bausch Health (backed by its Salix division) were ranked as the top companies best poised to deliver […]
Persephone Biosciences Inc., a biotechnology company that designs microbiome therapeutics and diagnostics to promote normal immune function in order to prevent and fight disease, today announced that it is developing an immune-boosting microbiome therapeutic to […]
Ilya Pharma a clinical stage biopharma company today announced that it has received a BIO-X® grant that will be matched with company funding to complete preclinical studies for two novel chemokine-based gene therapy candidates, ILP100 […]
Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbiome, today announced a collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, […]